Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program;Resistencia de Mycobacterium tuberculosis a los, antimicrobianos en Orizaba, Veracruz. Implicaciones para el programa de prevención y control de la tuberculosis

Revista de Investigacion Clinica

Volumn 53, Issue 4, 2001, Pages 315-323

  García García, Ma De Lourdes ^a,b   Sifuentes Osornio, José ^b   Jiménez Corona, Ma Eugenia ^a   Ponce de León, Alfredo ^b   Jiménez Corona, Aída ^a   Bobadilla Del Valle, Miriam ^b   Palacios Martínez, Manuel ^a   Canales, Guadalupe ^c   Sanginés, Agustín ^c   Jaramillo, Yolanda ^d   Martínez Gamboa, Areli ^b   Balandrano, Susana ^e   Valdespino Gómez, José Luis ^a   Small, Peter ^f  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c Jurisdiccion Sanit de Orizaba ^*  (Mexico)

^d HÔPITAL DU BOCAGE   (France)

^e Inst Nac Referencia Diagnostico E

^f STANFORD UNIVERSITY   (United States)

Author keywords

Directly observed therapy; Drug resistance; Multidrug resistance; Mycobacterium tuberculosis; Short course

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; COUGHING; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEXICO; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPUTUM CULTURE; SPUTUM SMEAR; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MALE; MEXICO; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 1642557115     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Valdespino JL, Velasco O, Escobar A, eds. Enfermedades Tropicales en México. Diagnóstico, tratamiento y distribución geográfica. México: Secretaría de Salud, 1994. p. 215-25.
2. Tapia R, Ruiz-C, Ferreira E. Epidemiología de la tuberculosis en Mexico. En: Sada E, Sifuentes J eds. Tuberculosis. México: McGraw-Hill Interamericana Editores; Mexico: 1995. p. 761-88. (Ramiro HM, Saita OK, eds. Temas de Medicina Interna; vol. 3).
3. Tapia R, Ruiz-C, Ferreira E. Epidemiología de la tuberculosis en Mexico. En: Sada E, Sifuentes J eds. Tuberculosis. México: McGraw-Hill Interamericana Editores; Mexico: 1995. p. 761-88. (Ramiro HM, Saita OK, eds. Temas de Medicina Interna; vol. 3).
4. World Health Organization. Treatment of tuberculosis. Guidelines for National Programmes, WHO/tb/97.220. 1997. Geneva, Switzerland.
5. García-García ML, Ponce de León A, Jiménez Corona ME, et al. Clinical consequences and transmissibility of drug resistant tuberculosis in Southern Mexico. Arch Int Med 2000; 160: 630-6.
6. García-García ML, Small PM, García-Sancho C, et al. Tuberculosis epidemiology and control in Veracruz , Mexico. Int J Epidemiol 1999; 28: 135-40.
7. Secretaría de Salud. Dirección General de Epidemiología. Boletín de Epidemiología. Sistema de Vigilancia Epidemiológica de la Tuberculosis. Semana 52, Volumen 16, Núm. 52, enero 2000.
8. Centro Latinoamericano de Demografía. Boletín Demográfico, América Latina, Proyecciones de población an̄os calendarios 1950-2000. CELADE 1991; 48: 183-90.
9. Secretaría de Salud. Norma Oficial Mexicana NOM-006-SSA2 1993, para la prevención y control de la tuberculosis en la atención primaria a la salud. Diario Oficial de la Federación, 1995; 26 de enero: 20-29.
10. Yáñez-Velasco LB, Quiróz G, Rodríguez J. Use of dots in pilot areas in Mexico. Int J Tub Lung Dis 1997; 1: S68.
11. Nolte FS, Metchock B. Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, and Yolken RH eds. Manual of clinical microbiology. 6th. edition, ASM Press; Washington, DC: 1995. p. 400-37
12. Instituto Nacional de Diagnóstico y Referencia Epidemiológicas. Manual de Técnicas y Procedimientos de Laboratorio en Tuberculosis. Secretaría de Salud, México, D. F., 1992. p. 9-20.
13. Van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-9.
14. Woellfer GB, Bradford WZ, Paz A, Small PM. A computer assisted molecular epidemiologic approach for confronting the re-emergence of tuberculosis. Am J Med Sci 1995; 311: 17-22.
15. Chaulk P, Moore-Rice K, Pizzo R, Chaisson R. Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995; 274: 945-51.
16. Wilkinson D. High compliance tuberculosis treatment programme in a rural community. Lancet 1994; 343: 646-8.
17. Van der Werf TS, Dade GK, Van der Mark TW. Patient compliance with tuberculosis treatment in Ghana: Factors influencing adherence to therapy in a rural service programme. Tubercle 1990; 71: 247-52.
18. Kin SJ, Bai GH, Hong YP. Drug resistant tuberculosis in Korea, 1994. Int J Tuberc Lung Dis 1997; 1: 302-8.
19. Styblo K, Dankova D, Drapela J, et al. Epidemiological and clinical study of tuberculosis in the district of Kolin. Czechoslovakia: Report for the first four years of the study (1961-1964). Bull World Health Organ 1967; 37: 819-74.
20. Boulhbal F, Khaled S, Tazir M. The interest of follow up of resistance of the tubercle bacillus in the evaluation of a programme. Bull Int Union Tuberc Lung Dis 1989; 64: 23-5.
21. Fujiwara PI, Larkin C, Frieden TR. Directly observed therapy in New York City: History implementation, results and challenges. Clin Chest Med 1997; 18: 135-48.
22. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-84.
23. Espinal MA, Kim SJ, Suarez PG, et. al. Standard short-course chemotherapy for drug-resistant tuberculosis: Treatment outcomes in 6 countries. JAMA 2000; 283: 2537-45.
24. Villatoro JA, Medina-Mora ME, Juárez F, Rojas E, Carreño S, Berenzon S. Drug use pathways among high school students of Mexico. Addiction 1998; 93: 1577-88.
25. Juárez F, Medina-Mora E, Berenzon S, et al. Antisocial behavior: its relation to selected sociodemographic variables and alcohol and drug use among Mexican students. Subs Use Misuse 1998; 33: 1437-59.
26. Friedman LN, Sullivan GM, Bevilaqua RP, Loscos R. Tuberculosis screening in alcoholics and drug addicts. Am Rev Respir Dis 1987; 136: 1188-92.